August 19th 2024
Genentech will leverage Sangamo’s proprietary capsid delivery platform and epigenetic regulation capabilities to develop genomic medicines to address certain neurodegenerative diseases.
February 2nd 2024
Under a new collaboration, Lonza and Oxford Nanopore aim to commercialize a CGMP-validated test for advanced analysis of mRNA products.
November 15th 2023
Demand for efficient tech transfer, as well as compliant on-time delivery, is rising.
November 1st 2023
A look at using best practice tech transfer methods for CGTs to increase process and analytics robustness while being scalable.
October 13th 2023
Under an expanded agreement, Cellares will provide proof-of-concept manufacturing for a second CAR-T cell therapy from Bristol Myers Squibb.